Loading...
PeptiDream Inc.
PPTDF•PNK
Healthcare
Biotechnology
$11.95
$0.06(0.50%)
PeptiDream Inc. (PPTDF) Financial Performance & Income Statement Overview
Review PeptiDream Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
62.57%
↑ 62.57%
Operating Income Growth
211.73%
↑ 211.73%
Net Income Growth
394.59%
↑ 394.59%
Operating Cash Flow Growth
91.97%
↑ 91.97%
Operating Margin
33.44%
↑ 33.44%
Gross Margin
67.46%
↑ 67.46%
Net Profit Margin
28.13%
↑ 28.13%
ROE
26.49%
↑ 26.49%
ROIC
17.00%
↑ 17.00%
PeptiDream Inc. (PPTDF) Income Statement & Financial Overview
Review PeptiDream Inc.'s (PPTDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.07B | $5.47B | $31.91B | $4.23B |
| Cost of Revenue | $3.11B | $2.89B | $3.43B | $2.75B |
| Gross Profit | $1.96B | $2.58B | $28.48B | $1.48B |
| Gross Profit Ratio | $0.39 | $0.47 | $0.89 | $0.35 |
| R&D Expenses | $1.70B | $826.64M | $781.14M | $690.66M |
| SG&A Expenses | $3.43B | $1.87B | $1.92B | $1.88B |
| Operating Expenses | $5.37B | $2.71B | $2.70B | $2.57B |
| Total Costs & Expenses | $8.48B | $5.60B | $6.13B | $5.32B |
| Interest Income | $0.00 | $0.00 | $185.41M | $149.80M |
| Interest Expense | $0.00 | $0.00 | $71.70M | $64.64M |
| Depreciation & Amortization | $554.09M | $540.04M | $522.68M | $631.66M |
| EBITDA | -$2.85B | $413.12M | $26.46B | -$317.43M |
| EBITDA Ratio | -$0.56 | $0.08 | $0.83 | -$0.08 |
| Operating Income | -$3.41B | -$126.92M | $25.78B | -$1.09B |
| Operating Income Ratio | -$0.67 | -$0.02 | $0.81 | -$0.26 |
| Other Income/Expenses (Net) | -$3.65M | -$314.33M | $68.63M | $79.72M |
| Income Before Tax | -$3.41B | -$441.25M | $25.85B | -$1.01B |
| Income Before Tax Ratio | -$0.67 | -$0.08 | $0.81 | -$0.24 |
| Income Tax Expense | -$806.53M | $136.51M | $7.08B | -$261.51M |
| Net Income | -$2.61B | -$304.74M | $18.77B | -$842.54M |
| Net Income Ratio | -$0.51 | -$0.06 | $0.59 | -$0.20 |
| EPS | -$20.10 | -$2.35 | $144.80 | -$6.50 |
| Diluted EPS | -$20.10 | -$2.35 | $144.60 | -$6.50 |
| Weighted Avg Shares Outstanding | $129.61M | $129.61M | $129.61M | $129.61M |
| Weighted Avg Shares Outstanding (Diluted) | $129.61M | $129.61M | $129.79M | $129.61M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan